Gary Milavetz

2.2k total citations
48 papers, 1.6k citations indexed

About

Gary Milavetz is a scholar working on Pharmacology, Physiology and Epidemiology. According to data from OpenAlex, Gary Milavetz has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmacology, 14 papers in Physiology and 13 papers in Epidemiology. Recurrent topics in Gary Milavetz's work include Cannabis and Cannabinoid Research (26 papers), Substance Abuse Treatment and Outcomes (12 papers) and Forensic Toxicology and Drug Analysis (9 papers). Gary Milavetz is often cited by papers focused on Cannabis and Cannabinoid Research (26 papers), Substance Abuse Treatment and Outcomes (12 papers) and Forensic Toxicology and Drug Analysis (9 papers). Gary Milavetz collaborates with scholars based in United States, Netherlands and South Korea. Gary Milavetz's co-authors include Timothy L. Brown, Gary Gaffney, Andrew Spurgin, Rebecca L. Hartman, David A. Gorelick, Marilyn A. Huestis, Russell S. Pierce, Miles Weinberger, Kanika Arora and Brian Kaskie and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Clinical Chemistry.

In The Last Decade

Gary Milavetz

45 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Milavetz United States 20 675 354 343 320 238 48 1.6k
Marco L.A. Sivilotti Canada 36 168 0.2× 151 0.4× 446 1.3× 324 1.0× 321 1.3× 135 3.8k
Michael F. Weaver United States 27 254 0.4× 1.2k 3.3× 412 1.2× 140 0.4× 118 0.5× 71 2.4k
Fatemeh Yazdi Canada 23 299 0.4× 169 0.5× 220 0.6× 105 0.3× 355 1.5× 58 2.0k
Ryan N. Hansen United States 14 573 0.8× 277 0.8× 243 0.7× 52 0.2× 301 1.3× 35 2.1k
Karl A. Sporer United States 26 271 0.4× 111 0.3× 421 1.2× 149 0.5× 285 1.2× 78 2.5k
Jeffrey L. Galinkin United States 27 329 0.5× 191 0.5× 274 0.8× 157 0.5× 1.5k 6.3× 73 3.0k
Gary M. Reisfield United States 20 266 0.4× 94 0.3× 190 0.6× 74 0.2× 238 1.0× 67 1.5k
Mary Barna Bridgeman United States 16 346 0.5× 128 0.4× 114 0.3× 140 0.4× 122 0.5× 55 1.3k
Russell R. Miller United States 27 169 0.3× 108 0.3× 782 2.3× 490 1.5× 258 1.1× 68 3.5k
Sarah Aldington New Zealand 25 463 0.7× 1.2k 3.4× 220 0.6× 1.6k 5.1× 133 0.6× 42 2.7k

Countries citing papers authored by Gary Milavetz

Since Specialization
Citations

This map shows the geographic impact of Gary Milavetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Milavetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Milavetz more than expected).

Fields of papers citing papers by Gary Milavetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Milavetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Milavetz. The network helps show where Gary Milavetz may publish in the future.

Co-authorship network of co-authors of Gary Milavetz

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Milavetz. A scholar is included among the top collaborators of Gary Milavetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Milavetz. Gary Milavetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Miller, Ryan, et al.. (2023). Predicting changes in driving performance in individuals who use cannabis following acute use based on self-reported readiness to drive. Accident Analysis & Prevention. 195. 107376–107376. 4 indexed citations
3.
4.
Brown, Timothy L., et al.. (2022). Sensitivity to dose or blood levels of alprazolam in predicting driving impairment. Traffic Injury Prevention. 23(sup1). 1 indexed citations
5.
Brown, Timothy L., et al.. (2022). Perceived effects of cannabis: Generalizability of changes in driving performance. Traffic Injury Prevention. 23(sup1). S8–S13. 2 indexed citations
6.
Brown, Timothy L., Gary Gaffney, Gary Milavetz, et al.. (2022). A study of self-reported personal cannabis use and state legal status and associations with engagement in and perceptions of cannabis-impaired driving. Traffic Injury Prevention. 23(sup1). S183–S186. 3 indexed citations
7.
Brown, Timothy L., et al.. (2021). Perceived effects of cannabis and changes in driving performance under the influence of cannabis. Traffic Injury Prevention. 22(sup1). S8–S13. 6 indexed citations
8.
Brown, Timothy L., et al.. (2021). Cannabis use and reported effects on driving among adults in Iowa. Traffic Injury Prevention. 22(sup1). S187–S189. 2 indexed citations
9.
Brooks‐Russell, Ashley, Timothy L. Brown, Julia Wrobel, et al.. (2021). Simulated driving performance among daily and occasional cannabis users. Accident Analysis & Prevention. 160. 106326–106326. 29 indexed citations
10.
Brown, Timothy L., et al.. (2021). Mechanisms of cannabis impairment: Implications for modeling driving performance. Forensic Science International. 328. 110902–110902. 9 indexed citations
11.
Brown, Timothy L., Christian Richard, Amir H. Meghdadi, et al.. (2020). EEG biomarkers acquired during a short, straight-line simulated drive to predict impairment from cannabis intoxication. Traffic Injury Prevention. 21(sup1). S130–S134. 7 indexed citations
12.
Arora, Kanika, Sara Honn Qualls, Julie Bobitt, et al.. (2019). Measuring Attitudes Toward Medical and Recreational Cannabis Among Older Adults in Colorado. The Gerontologist. 60(4). e232–e241. 25 indexed citations
13.
Kaskie, Brian, Padmaja Ayyagari, Gary Milavetz, Dan M. Shane, & Kanika Arora. (2017). The Increasing Use of Cannabis Among Older Americans: A Public Health Crisis or Viable Policy Alternative?. The Gerontologist. 57(6). 1166–1172. 51 indexed citations
14.
Hartman, Rebecca L., Timothy L. Brown, Gary Milavetz, et al.. (2016). Cannabis effects on driving longitudinal control with and without alcohol. Journal of Applied Toxicology. 36(11). 1418–1429. 85 indexed citations
15.
Hartman, Rebecca L., Timothy L. Brown, Gary Milavetz, et al.. (2015). Cannabis effects on driving lateral control with and without alcohol. Drug and Alcohol Dependence. 154. 25–37. 180 indexed citations
16.
Brown, Timothy L., et al.. (2015). Do Drowsy Driver Drugs Differ?. 4 indexed citations
17.
Brown, Timothy L., Gary Milavetz, & Daryl J. Murry. (2013). Alcohol, drugs and driving: implications for evaluating driver impairment.. PubMed. 57. 23–32. 11 indexed citations
18.
Dusdieker, Lois B., Jody R. Murph, & Gary Milavetz. (2000). How Much Antibiotic Suspension Is Enough?. PEDIATRICS. 106(1). e10–e10. 7 indexed citations
19.
Milavetz, Gary, et al.. (1991). Corticosteroids for Acute, Severe Asthma. DICP. 25(1). 72–79. 8 indexed citations
20.
Vaughan, Leigh M., Gary Milavetz, Miles Weinberger, Gary D. Smith, & James B. Harris. (1988). Oral Bioavailability of Slow-Release Theophylline from Unencapsulated Beads in Preschool Children with Chronic Asthma. Therapeutic Drug Monitoring. 10(4). 395–400. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco L.A. Sivilotti Breakdown of academic impact, for papers by Michael F. Weaver Breakdown of academic impact, for papers by Fatemeh Yazdi Breakdown of academic impact, for papers by Ryan N. Hansen Breakdown of academic impact, for papers by Karl A. Sporer Breakdown of academic impact, for papers by Jeffrey L. Galinkin Breakdown of academic impact, for papers by Gary M. Reisfield Breakdown of academic impact, for papers by Mary Barna Bridgeman Breakdown of academic impact, for papers by Russell R. Miller Breakdown of academic impact, for papers by Sarah Aldington
Rankless by CCL
2026